Paola Fugazzola
Emergency, General and Trauma Surgery dept., Bufalini hospital, Cesena, Italy
Luca Ansaloni
Emergency, General and Trauma Surgery dept., Bufalini hospital, Cesena, Italy
Massimo Sartelli
General Surgery Department, Macerata Hospital, Macerata, Italy
Fausto Catena
General and Emergency Surgery dept., Maggiore hospital, Parma, Italy
Enrico Cicuttin
Emergency, General and Trauma Surgery dept., Bufalini hospital, Cesena, Italy
Gioacchino Leandro
National Institute of Gastroenterology “S. De Bellis” Research Hospital, Castellana Grotte, Italy
Gian Luigi de' Angelis
Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy
Federica Gaiani
Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy
Francesco Di Mario
Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy
Matteo Tomasoni
Emergency, General and Trauma Surgery dept., Bufalini hospital, Cesena, Italy
Federico Coccolini
Emergency, General and Trauma Surgery dept., Bufalini hospital, Cesena, Italy
Keywords
advanced gastric cancer, chemotherapy, hipec, intraperitoneal, surgery, definition, metastasis, carcinosis
Abstract
Gastric cancer is a common disease with high mortality. The definition of advanced gastric cancer is still debated. Radical surgery associated to appropriate systemic and intra-abdominal chemotherapy is the gold standard treatment. In presence of peritoneal carcinosis, reaching a complete cytoreduction is the key to achieve long-term survival. Adequate lymphadenectomy is also fundamental. Conversion therapy could be applied to selected IV stage patients. No definitive evidences exist regarding the oncological and surgical superiority of mini-invasive approaches over the classical open techniques.